Nocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next?
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2020.1817374
Abstract: ABSTRACT Introduction The use of biosimilars for the treatment of patients with chronic inflammatory bowel diseases (IBD) showed to be a valid strategy to reduce the economic burden of biologics on health-care costs and to… read more here.
Keywords: nocebo effect; inflammatory bowel; effect biosimilars; effect ... See more keywords